Anlezark G M, Blackwood D H, Meldrum B S, Ram V J, Neumeyer J L
Psychopharmacology (Berl). 1983;81(2):135-9. doi: 10.1007/BF00429007.
The anticonvulsant action of various aporphine derivatives that act on dopamine receptors has been investigated in two genetically determined animal models--DBA/2 mice with sound-induced seizures and baboons Papio papio with photically-induced seizures. Protection against the clonic and tonic phases of the seizures response in DBA/2 mice was seen for 15-60 min after (-)2,10,11-trihydroxy-N-n-propylnoraporphine (1.25 mg/kg) and (-)10,11-methyl-enedioxy-N-n-propylnoraporphine (0.625-1.25 mg/kg) and for 30-60 min after (-)2,10,11-trihydroxyaporphine (31.25 mg/kg). Short-lasting protection (up to 30 min) was seen following (-)2,10,11-trihydroxy-N-ethyl-noraporphine (1.25-6.25 mg/kg). Changes in audiogenic seizure susceptibility were accompanied by piloerection, ptosis and loss of spontaneous locomotor and exploratory behaviour. No protection was seen after (-)norapomorphine (0.05-18.75 mg/kg). All the compounds (including norapomorphine) significantly lowered rectal temperature, although the time course of this effect was often longer than that of protection against audiogenic seizures. In baboons, marked reductions in photomyoclonic responses were seen following (-)10,11-methylenedioxy-N-n-propylnoraporphine (0.25 mg/kg, lasting up to 2h); (-)2,10,11-trihydroxy-N-n-propylnoraporphine (0.5-2.5 mg/kg, lasting up to 7 h); (-)2,10,11-trihydroxyaporphine (5 mg/kg, duration of action 1-4 h) and (-)2,10,11-trihydroxy-N-ethylnoraporphine (6.25 mg/kg, lasting 2 h). Little change in responsiveness followed administration of (-)norapomorphine 1.25 or 6.25 mg/kg. Changes in photosensitivity were accompanied by yawning and pupil dilatation. (-)10,11-Methylenedioxy-N-n-propylnoraporphine (0.5-6.25 mg/kg) was also administered orally in baboons.(ABSTRACT TRUNCATED AT 250 WORDS)
已在两种基因决定的动物模型中研究了作用于多巴胺受体的各种阿朴菲衍生物的抗惊厥作用,这两种模型分别是对声音诱发癫痫敏感的DBA/2小鼠和对光诱发癫痫敏感的狒狒(豚尾狒狒)。给予(-)2,10,11 - 三羟基 - N - 正丙基去甲阿朴菲(1.25毫克/千克)和(-)10,11 - 亚甲二氧基 - N - 正丙基去甲阿朴菲(0.625 - 1.25毫克/千克)后,DBA/2小鼠癫痫发作反应的阵挛期和强直期得到15 - 60分钟的保护;给予(-)2,10,11 - 三羟基阿朴菲(31.25毫克/千克)后得到30 - 60分钟的保护。给予(-)2,10,11 - 三羟基 - N - 乙基去甲阿朴菲(1.25 - 6.25毫克/千克)后有短暂保护作用(长达30分钟)。声音诱发癫痫易感性的变化伴有竖毛、眼睑下垂以及自发运动和探究行为的丧失。给予(-)去甲阿朴吗啡(0.05 - 18.75毫克/千克)后未观察到保护作用。所有化合物(包括去甲阿朴吗啡)均显著降低直肠温度,尽管这种作用的时间进程通常比抗声音诱发癫痫发作的时间进程更长。在狒狒中,给予(-)10,11 - 亚甲二氧基 - N - 正丙基去甲阿朴菲(0.25毫克/千克,作用长达2小时)、(-)2,10,11 - 三羟基 - N - 正丙基去甲阿朴菲(0.5 - 2.5毫克/千克,作用长达7小时)、(-)2,10,11 - 三羟基阿朴菲(5毫克/千克,作用持续1 - 4小时)和(-)2,10,11 - 三羟基 - N - 乙基去甲阿朴菲(6.25毫克/千克,作用持续2小时)后,光肌阵挛反应显著降低。给予1.25或6.25毫克/千克的(-)去甲阿朴吗啡后反应变化不大。光敏性变化伴有打哈欠和瞳孔扩张。(-)10,11 - 亚甲二氧基 - N - 正丙基去甲阿朴菲(0.5 - 6.25毫克/千克)也经口给予狒狒。(摘要截短于250字)